forum

MOREPENLAB Share Price Discussion

Morepen Laboratories Ltd.
Sector: Pharmaceuticals and health care
... Read more
MOREPENLAB Share Price *
18.3 +0.15 (0.83%)
* (quote may be delayed)

MOREPENLAB Discussion Forum

Stocks in the news: DLF, Aavas Financiers, TCS, NBCC, Kaveri Seed, Wipro, Mindtree, TRF
DLF, Aavas Financiers, TCS, NBCC, Wipro, Mindtree
Moneycontrol
Like
reply
Reply
share
Share
Morepen Lab Standalone June 2019 Net Sales at Rs 189.47 crore, up 25.61% Y-o-Y
moneycontrol.com
Like
reply
Reply
share
Share
Morepen Lab Consolidated June 2019 Net Sales at Rs 202.98 crore, up 23.97% Y-o-Y
www.moneycontrol.com
Like
reply
Reply
share
Share
  • MOREPENLAB - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization1,387.63
    Enterprise Value1,515.93
    Price to Earnings53.37
    Price to Book Value5.53
    Return on Capital Employed0.08
    Return on Equity0.1
    Face Value2
    Dividend YieldNA
  • MOREPENLAB Share Price - Technicals

    keyboard_arrow_down
    MOREPENLAB - 52 Week High₹29
    MOREPENLAB - 52 Week Low₹14.55
  • MOREPENLAB Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 1818.2518.4518.0518.25
    Sep 1718.3518.951818.15
    Sep 1617.418.717.3518.25
    Sep 1317.81817.317.55
    Sep 1217.218.3517.0518
  • MOREPENLAB Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹16.54
    30 Day Moving Average₹16.71
    50 Day Moving Average₹16.74
    100 Day Moving Average₹17.74
    200 Day Moving Average₹18.61
  • MOREPENLAB - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue561537.040.04
    Operating Profit6059.90
    Profit Before Tax2623.040.13
    Net Income2623.040.13
  • MOREPENLAB - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Shareholder's Funds251351.9-0.29
    Total Liabilities340315.630.08
    Total Assets591547.880.08
  • MOREPENLAB - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity6164.55-0.05
    Cash from Investing Activity-24-14.510.65
    Cash from Financing Activity-38-46.92-0.19
    Net Cash Flow-13.11-1.32
  • MOREPENLAB - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.040.04
    Return on Equity0.10.07
    Return on Capital Employed0.080.08
  • MOREPENLAB - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.52
    3 Year CAGR Growth in Operating Profit0.29
    3 Year CAGR Growth in EBIDTA0.31
    3 Year CAGR Growth in Net Income43.83
    3 Yr CAGR Growth - Diluted EPS57
  • MOREPENLAB - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.85
    5 Year CAGR Growth in Operating Profit1.07
    5 Year CAGR Growth in EBIDTA0.82
    5 Year CAGR Growth in Net Income2.15
    3 Yr CAGR Growth - Diluted EPS2.16
  • MOREPENLAB Share Price - Recent News

    keyboard_arrow_down
    NewsBot
    Yesterday 1:53 PM
    Stocks in the news: DLF, Aavas Financiers, TCS, NBCC, Kaveri Seed, Wipro, Mindtree, TRF
    Moneycontrol
    NewsBot
    Aug 13 11:13 PM
    Morepen Lab Standalone June 2019 Net Sales at Rs 189.47 crore, up 25.61% Y-o-Y
    moneycontrol.com
    NewsBot
    Aug 13 11:13 PM
    Morepen Lab Consolidated June 2019 Net Sales at Rs 202.98 crore, up 23.97% Y-o-Y
    www.moneycontrol.com
    NewsBot
    Mar 25 11:02 PM
    NewsBot
    Feb 5 6:22 PM
    NewsBot
    Feb 5 6:22 PM
    NewsBot
    Nov 2 6:42 PM
  • MOREPENLAB - Related Communities

    keyboard_arrow_down
    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.